Abacavir/lamivudine/zidovudine
![](/Images/godic/202502/17/Abacavir,_lamivudine_and_zidovudine.svg1846.png")
Abacavir/lamivudine/zidovudine (INNs, trade name Trizivir) is a pharmaceutical treatment for HIV infection. It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and now marketed by its joint venture with Pfizer, ViiV Healthcare: